Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABHD6 | Q9BV23 | 2/20 | 0.33 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.32 |
| ▸ | NPY1R | P25929 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.31 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.30 |
| ▸ | ATXN2 | Q99700 | 2/20 | 0.30 |
| ▸ | DGAT2 | Q96PD7 | 1/20 | 0.30 |
| ▸ | KIT | P10721 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26962322 | 0.94 | PDE4B (0.33) | PDE4BNPY1RKIT | |
| SCHEMBL26961949 | 0.89 | GRM2 (0.32) | NPY1RKIT | |
| SCHEMBL26962172 | 0.89 | SRC (0.36) | ABHD6DAGLAP2RX7PDE4BNPY1R | |
| SCHEMBL26962067 | 0.85 | PDE4B (0.32) | PDE4BNPY1R | |
| SCHEMBL26961712 | 0.85 | THRB (0.33) | PDE4BNPY1R | |
| SCHEMBL26961950 | 0.84 | GRM2 (0.32) | — | |
| SCHEMBL26961745 | 0.84 | PDE4B (0.40) | PDE4BNPY1R | |
| SCHEMBL26961737 | 0.83 | XIAP (0.36) | PDE4BNPY1RKIT | |
| SCHEMBL26961787 | 0.82 | XIAP (0.32) | NPY1RKIT | |
| SCHEMBL26961664 | 0.81 | GCGR (0.35) | NPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4291558-A1 | BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER | F. Hoffmann-La Roche AG (CH) | 2023-12-20 | — | — | EP | disclosed |